Karyopharm announces key changes to its commercial leadership team

Newton, mass., june 8, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced key management changes to its commercial organization, including the appointment of sohanya cheng, mba, as senior vice president of sales and commercial operations.

KPTI Ratings Summary

KPTI Quant Ranking